secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2024-10-18T23:59:59+00:00
Accession:  0001753926-24-001716
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella receives Nasdaq delisting notice for equity deficiency; hearing set for Dec 12
--------------------------------------------------------------------------------

- Nasdaq notified Lipella of delisting for stockholders' equity of $1.7M, below $2.5M minimum.
- Company appealed by Oct 23, 2024; hearing before Nasdaq Hearings Panel set for Dec 12, 2024.
- Trading suspension stayed pending hearing; stock continues trading on Nasdaq during appeal.
- Bid price non-compliance also outstanding; reverse split approved to address minimum bid requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624001716/0001753926-24-001716-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624001716/g084492_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-24-001716

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer